Published Date: 04 Nov 2025
Indoor hydroponic gardening—a method of growing plants using nutrient-rich water instead of soil—could help cancer patients develop better mental health, eat a healthier diet and enjoy a better overall quality of life.
Read Full NewsAnemia Correction Before Colorectal Surgery Yields No Postoperative Gains
Mease discussed his hopes for the new approval's impact on the fibromyalgia field.
The rheumatology month in review emphasizes new approvals and the latest comparative research.
Q3 2025 saw several new first targeted therapies for rare and more individualized indications in a number of fields.
Q3 2025 saw a number of exciting approvals and data on promising therapies in development.
Prajapati discussed the impact of the expanded approval of guselkumab to pediatric PsO and psoriatic arthritis.
Sonelokimab meets ACR50 primary endpoint in a phase 2 trial.
1.
AI Unlocks Benefits of Prostate Cancer Treatment.
2.
How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs
3.
According to a study, breast cancer in Syrian refugees tends to be diagnosed at an earlier stage and with more advanced tumors.
4.
Alternative breast imaging techniques beyond mammography.
5.
New Zealand and Australian breast cancer rates among the highest in the world, global study finds
1.
Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression
2.
Uncovering the Mysteries of the RDW Blood Test
3.
Boosting Checkpoint Immunotherapy in Hodgkin Lymphoma with JAK Inhibition: Advances & Insights
4.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
5.
Unlocking the Benefits of Eltrombopag: A Comprehensive Guide
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
2.
Understanding the causes of anemia in adults beyond nutritional deficiencies
3.
Efficient Management of First line ALK-rearranged NSCLC - Part II
4.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation